EXAS
USDExact Sciences Corporation Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$70.070
Máximo
$72.810
Mínimo
$67.970
Volumen
1.54M
Fundamentos de la Empresa
Capitalización de Mercado
13.2B
Industria
Diagnostics & Research
País
United States
Estadísticas de Negociación
Volumen Promedio
2.95M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.
Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80
Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.
Exact Sciences to Participate in November Investor Conference
Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.